VYNE Therapeutics Inc. Made Big Gain
VYNE Therapeutics Inc. (VYNE:NASDAQ) rocketted at $0.6, representing a gain of 49%. On Wed, Dec 17, 2025, VYNE:NASDAQ hit a New 2-Week High of $0.6. The stock got featured on our News Catalysts scanner on Wed, Dec 17, 2025 at 09:38 AM in the 'AGREEMENT' category. From Wed, Dec 03, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Dec 17, 2025 at $0.75 with a volume of 256M+.
About VYNE Therapeutics Inc. (VYNE:NASDAQ)
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
Top 10 Gainers:
- Mega Fortune Company Limited (MGRT:NASDAQ), 143.93%
- Smart for Life, Inc. (SMFL:NASDAQ), 100%
- cbdMD, Inc. (YCBD:NYSEMKT), 58.74%
- Agape ATP Corporation (ATPC:NASDAQ), 56.44%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 48.99%
- Inspirato Incorporated (ISPO:NASDAQ), 46.83%
- Creative Global Technology Holdings Limited (CGTL:NASDAQ), 31.3%
- AlphaVest Acquisition Corp (ATMV:NASDAQ), 31.3%
- Globavend Holdings Limited (GVH:NASDAQ), 28.14%
- DBV Technologies S.A. (DBVT:NASDAQ), 25.42%